Skip to main content
Premium Trial:

Request an Annual Quote

Mara Aspinall

Mara Aspinall was named executive chairman of the Lifeprint Group's board of directors. Aspinall currently is CEO of the consulting firm Health Catalysts. She was previously the president and CEO of Roche's Ventana Medical Systems. She also spent more than a decade at Genzyme, where she held various leadership roles, including president of Genzyme Genetics and Genzyme Pharmaceuticals.

The appointment was announced by GenePeeks, a firm held by Lifeprint, which uses next-generation sequencing to help parents assess the risk of inherited diseases for their future children. 

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.